Goodbye Biotech "Growth Bubble"; Hello Pharma "M&A Bubble" - Novartis Enters Fray With $25 Billion In Transactions
April 22, 2014 at 09:58 AM EDT
While the rest of the market has been largely quiet as earnings week unfolds, it have been the pharma companies that has stolen the spotlight in the past few days.